Findlay Park Partners LLP Icu Medical Inc Transaction History

Findlay Park Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$186.8 - $260.0 $122 Million - $170 Million	-655,299 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$190.83 - $215.73 $3.02 Million - $3.42 Million	-15,837 Reduced 2.36%	655,299 $135 Million
Q1 2021 May 14, 2021	BUY	$197.58 - $222.54 $28.1 Million - $31.7 Million	142,311 Added 26.91%	671,136 $138 Million
Q4 2020 Feb 11, 2021	BUY	$177.6 - $214.65 $14 Million - $16.9 Million	78,825 Added 17.52%	528,825 $113 Million
Q3 2019 Nov 05, 2019	BUY	$154.21 - $257.38 $23.1 Million - $38.6 Million	150,000 Added 50.0%	450,000 $71.8 Million
Q2 2019 Aug 07, 2019	BUY	$212.8 - $251.91 $63.8 Million - $75.6 Million	300,000 New	300,000 $75.6 Million

276

24.1M

28.3K

35.5K

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $4.19B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

Get notified when there are updates to the investment portfolio of Findlay Park Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Findlay Park Partners LLP with notifications on news.